{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:40:56Z","timestamp":1767850856116,"version":"3.49.0"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"US National Institutes of Health","doi-asserted-by":"crossref","award":["DA041781"],"award-info":[{"award-number":["DA041781"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"US National Institutes of Health","doi-asserted-by":"crossref","award":["DA042581"],"award-info":[{"award-number":["DA042581"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"US National Institutes of Health","doi-asserted-by":"crossref","award":["DA042499"],"award-info":[{"award-number":["DA042499"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"US National Institutes of Health","doi-asserted-by":"crossref","award":["DA041883"],"award-info":[{"award-number":["DA041883"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NARSAD Independent Investigator Award from the Brain and Behavior Research Foundation"},{"DOI":"10.13039\/100014269","name":"Philippe Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014269","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Behavioral Sciences"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.cobeha.2018.10.002","type":"journal-article","created":{"date-parts":[[2018,10,30]],"date-time":"2018-10-30T20:52:12Z","timestamp":1540932732000},"page":"69-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Pain And Opioid Systems, Implications In The Opioid Epidemic"],"prefix":"10.1016","volume":"26","author":[{"given":"Nicolas","family":"Massaly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose A","family":"Mor\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cobeha.2018.10.002_bib0005","series-title":"Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research","author":"Institute of Medicine (US) Committee on Advancing Pain Research, Care, and Education","year":"2011"},{"key":"10.1016\/j.cobeha.2018.10.002_bib0010","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.jpain.2010.07.002","article-title":"The Prevalence of Chronic Pain in United States Adults: Results of an Internet-Based Survey","volume":"11","author":"Johannes","year":"2010","journal-title":"J. Pain"},{"key":"10.1016\/j.cobeha.2018.10.002_bib0015","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jpain.2008.05.005","article-title":"Common chronic pain conditions in developed and developing countries: gender and age differences and comorbidity with depression-anxiety disorders","volume":"9","author":"Tsang","year":"2008","journal-title":"J. Pain Off. J. Am. Pain Soc."},{"key":"10.1016\/j.cobeha.2018.10.002_sbref0020","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJMra1507771","article-title":"Opioid Abuse in Chronic Pain--Misconceptions and Mitigation Strategies","volume":"374","author":"Volkow","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0025","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1377\/hlthaff.2016.0448","article-title":"Mandatory Provider Review And Pain Clinic Laws Reduce The Amounts Of Opioids Prescribed And Overdose Death Rates","volume":"35","author":"Dowell","year":"2016","journal-title":"Health Aff. Proj. Hope"},{"key":"10.1016\/j.cobeha.2018.10.002_bib0030","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1146\/annurev-publhealth-031914-122957","article-title":"The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction","volume":"36","author":"Kolodny","year":"2015","journal-title":"Annu. Rev. Public Health"},{"key":"10.1016\/j.cobeha.2018.10.002_bib0035","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC Guideline for Prescribing Opioids for Chronic Pain--United States","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.cobeha.2018.10.002_bib0040","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.drugalcdep.2015.10.027","article-title":"Non-Medical Use of Prescription Pain Medications and Increased Emergency Department Utilization: Results of a National Survey","volume":"157","author":"Frank","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0045","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.tips.2016.08.002","article-title":"Allostatic Mechanisms of Opioid Tolerance Beyond Desensitization and Downregulation","volume":"37","author":"Cahill","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0050","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1152\/physrev.2001.81.1.299","article-title":"Cellular and synaptic adaptations mediating opioid dependence","volume":"81","author":"Williams","year":"2001","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0055","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/ALN.0b013e318238bba6","article-title":"Molecular Mechanisms of Opioid Receptor-Dependent Signaling and Behavior","volume":"115","author":"Al-Hasani","year":"2011","journal-title":"Anesthesiology"},{"key":"10.1016\/j.cobeha.2018.10.002_bib0060","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/bph.12696","article-title":"In vivo profiling of seven common opioids for antinociception, constipation and respiratory depression: no two opioids have the same profile","volume":"172","author":"Kuo","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0065","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1124\/pr.112.007138","article-title":"Mu Opioids and Their Receptors: Evolution of a Concept","volume":"65","author":"Pasternak","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0070","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1124\/pr.112.005942","article-title":"Regulation of \u03bc-Opioid Receptors: Desensitization, Phosphorylation, Internalization, and Tolerance","volume":"65","author":"Williams","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0075","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2016.00480","article-title":"A Trigger for Opioid Misuse: Chronic Pain and Stress Dysregulate the Mesolimbic Pathway and Kappa Opioid System","volume":"10","author":"Massaly","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0080","first-page":"1859","article-title":"Causes and consequences of inadequate management of acute pain","volume":"11","author":"Sinatra","year":"2010","journal-title":"Pain Med. Malden Mass"},{"key":"10.1016\/j.cobeha.2018.10.002_bib0085","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s12630-014-0275-x","article-title":"Optimizing pain management to facilitate Enhanced Recovery After Surgery pathways","volume":"62","author":"Tan","year":"2015","journal-title":"Can. J. Anaesth. J. Can. Anesth."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0090","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1213\/ANE.0b013e318249d36e","article-title":"The prevention of chronic postsurgical pain using gabapentin and pregabalin: a combined systematic review and meta-analysis","volume":"115","author":"Clarke","year":"2012","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.cobeha.2018.10.002_sbref0095","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/nm.4262","article-title":"Loss of \u03bc opioid receptor signaling in nociceptors, but not microglia, abrogates morphine tolerance without disrupting analgesia","volume":"23","author":"Corder","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0100","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0092-8674(02)00666-9","article-title":"Opioid Tolerance\u2013In Search of the Holy Grail","volume":"108","author":"Kieffer","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.cobeha.2018.10.002_bib0105","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0196-9781(00)00227-8","article-title":"Tissue distribution of the opioid receptor-like (ORL1) receptor","volume":"21","author":"Mollereau","year":"2000","journal-title":"Peptides"},{"key":"10.1016\/j.cobeha.2018.10.002_bib0110","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0014-5793(94)80235-1","article-title":"ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization","volume":"341","author":"Mollereau","year":"1994","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0115","doi-asserted-by":"crossref","DOI":"10.1111\/bph.14225","article-title":"Analysis of the distribution of spinal NOP receptors in a chronic pain model using NOP-eGFP knock-in mice","author":"Ozawa","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cobeha.2018.10.002_sbref0120","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1124\/pr.114.009209","article-title":"Nociceptin\/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems","volume":"68","author":"Toll","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0125","doi-asserted-by":"crossref","first-page":"7011","DOI":"10.1021\/acs.jmedchem.5b01499","article-title":"Nociceptin Opioid Receptor (NOP) as a Therapeutic Target: Progress in Translation from Preclinical Research to Clinical Utility","volume":"59","author":"Zaveri","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0130","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1124\/jpet.117.241042","article-title":"Cebranopadol Blocks the Escalation of Cocaine Intake and Conditioned Reinstatement of Cocaine Seeking in Rats","volume":"362","author":"de Guglielmo","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0135","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/npp.2016.171","article-title":"Genetic Deletion of the Nociceptin\/Orphanin FQ Receptor in the Rat Confers Resilience to the Development of Drug Addiction","volume":"42","author":"Kallupi","year":"2017","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0140","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/bs.pbr.2015.07.018","article-title":"Emerging Targets for Addiction Neuropharmacology; From Mechanisms to Therapeutics","volume":"224","author":"Ubaldi","year":"2016","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0145","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1152\/physrev.00005.2009","article-title":"Reward processing by the opioid system in the brain","volume":"89","author":"Le Merrer","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0150","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/0166-2236(88)90093-8","article-title":"Anatomy of CNS opioid receptors","volume":"11","author":"Mansour","year":"1988","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0155","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.tips.2006.11.003","article-title":"Trafficking of delta-opioid receptors and other G-protein-coupled receptors: implications for pain and analgesia","volume":"28","author":"Cahill","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0160","doi-asserted-by":"crossref","DOI":"10.1007\/164_2017_39","article-title":"Ligand-Directed Signaling at the Delta Opioid Receptor","author":"Vicente-Sanchez","year":"2017","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0165","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.neuron.2015.08.019","article-title":"Distinct Subpopulations of Nucleus Accumbens Dynorphin Neurons Drive Aversion and Reward","volume":"87","author":"Al-Hasani","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.cobeha.2018.10.002_bib0170","doi-asserted-by":"crossref","first-page":"11614","DOI":"10.1523\/JNEUROSCI.3769-07.2007","article-title":"Stress-induced p38 mitogen-activated protein kinase activation mediates kappa-opioid-dependent dysphoria","volume":"27","author":"Bruchas","year":"2007","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0175","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.brainres.2009.08.062","article-title":"The dynorphin\/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors","volume":"1314","author":"Bruchas","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0180","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/S0022-3565(25)39324-9","article-title":"Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies","volume":"266","author":"Devine","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0185","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.brainres.2009.09.074","article-title":"Dynorphin, stress, and depression","volume":"1314","author":"Knoll","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0190","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0893-133X(00)00195-0","article-title":"Drug addiction, dysregulation of reward, and allostasis","volume":"24","author":"Koob","year":"2001","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0195","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1523\/JNEUROSCI.4458-07.2008","article-title":"The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system","volume":"28","author":"Land","year":"2008","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0200","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/npp.2013.236","article-title":"Pain-related depression of the mesolimbic dopamine system in rats: expression, blockade by analgesics, and role of endogenous \u03ba-opioids","volume":"39","author":"Leitl","year":"2014","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0205","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a012005","article-title":"Roles of nucleus accumbens CREB and dynorphin in dysregulation of motivation","volume":"3","author":"Muschamp","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0210","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1523\/JNEUROSCI.5973-10.2011","article-title":"Activation of CREB in the nucleus accumbens shell produces anhedonia and resistance to extinction of fear in rats","volume":"31","author":"Muschamp","year":"2011","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0215","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0304-3959(88)90225-4","article-title":"Motivational effects of opioids in an animal model of prolonged inflammatory pain: alteration in the effects of kappa- but not of mu-receptor agonists","volume":"35","author":"Shippenberg","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.cobeha.2018.10.002_bib0220","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/7854_2014_344","article-title":"The Self-administration of Analgesic Drugs in Experimentally Induced Chronic Pain","volume":"20","author":"Wade","year":"2014","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0225","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejphar.2013.01.076","article-title":"Opioids, sensory systems and chronic pain","volume":"716","author":"Stein","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0230","doi-asserted-by":"crossref","first-page":"20709","DOI":"10.1073\/pnas.1214605109","article-title":"Pain relief produces negative reinforcement through activation of mesolimbic reward-valuation circuitry","volume":"109","author":"Navratilova","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cobeha.2018.10.002_sbref0235","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1097\/j.pain.0000000000000798","article-title":"Reward, motivation and emotion of pain and its relief","volume":"158","author":"Porreca","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.cobeha.2018.10.002_bib0240","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1098\/rstb.2006.1854","article-title":"Role of brain dopamine in food reward and reinforcement","volume":"361","author":"Wise","year":"2006","journal-title":"Philos. Trans. R. Soc. B Biol. Sci."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0245","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/npp.2013.261","article-title":"The development and maintenance of drug addiction","volume":"39","author":"Wise","year":"2014","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0250","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.neuron.2014.04.030","article-title":"Separate GABA afferents to dopamine neurons mediate acute action of opioids, development of tolerance, and expression of withdrawal","volume":"82","author":"Matsui","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.cobeha.2018.10.002_bib0255","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.coph.2016.11.007","article-title":"Biased mu-opioid receptor ligands: a promising new generation of pain therapeutics","volume":"32","author":"Siuda","year":"2017","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0260","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/sj.npp.1300527","article-title":"Direct evidence for the involvement of the mesolimbic kappa-opioid system in the morphine-induced rewarding effect under an inflammatory pain-like state","volume":"30","author":"Narita","year":"2005","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0265","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.tips.2010.04.003","article-title":"Neuropathic and chronic pain stimuli downregulate central mu-opioid and dopaminergic transmission","volume":"31","author":"Niikura","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0270","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.neuron.2018.08.044","article-title":"Kappa Opioid Receptor Distribution and Function in Primary Afferents","volume":"99","author":"Snyder","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.cobeha.2018.10.002_bib0275","doi-asserted-by":"crossref","first-page":"12217","DOI":"10.1523\/JNEUROSCI.1053-15.2015","article-title":"Inflammatory Pain Promotes Increased Opioid Self-Administration: Role of Dysregulated Ventral Tegmental Area \u03bc Opioid Receptors","volume":"35","author":"Hip\u00f3lito","year":"2015","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0280","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/sj.npp.1300527","article-title":"Direct evidence for the involvement of the mesolimbic kappa-opioid system in the morphine-induced rewarding effect under an inflammatory pain-like state","volume":"30","author":"Narita","year":"2005","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.cobeha.2018.10.002_sbref0285","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nn.4199","article-title":"The indirect pathway of the nucleus accumbens shell amplifies neuropathic pain","volume":"19","author":"Ren","year":"2016","journal-title":"Nat. Neurosci"},{"key":"10.1016\/j.cobeha.2018.10.002_bib0290","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1126\/science.1253994","article-title":"Chronic pain. Decreased motivation during chronic pain requires long-term depression in the nucleus accumbens","volume":"345","author":"Schwartz","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.cobeha.2018.10.002_bib0295","doi-asserted-by":"crossref","first-page":"8442","DOI":"10.1523\/JNEUROSCI.4036-14.2015","article-title":"Microglia disrupt mesolimbic reward circuitry in chronic pain","volume":"35","author":"Taylor","year":"2015","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0300","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/FBP.0b013e3283618ac8","article-title":"Changes in morphine reward in a model of neuropathic pain","volume":"24","author":"Cahill","year":"2013","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0305","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1046\/j.1471-4159.2002.01071.x","article-title":"Suppression of the morphine-induced rewarding effect in the rat with neuropathic pain: implication of the reduction in mu-opioid receptor functions in the ventral tegmental area","volume":"82","author":"Ozaki","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0310","doi-asserted-by":"crossref","first-page":"8442","DOI":"10.1523\/JNEUROSCI.4036-14.2015","article-title":"Microglia disrupt mesolimbic reward circuitry in chronic pain","volume":"35","author":"Taylor","year":"2015","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0315","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.bbrc.2014.05.025","article-title":"Upregulation of tumor necrosis factor-alpha in nucleus accumbens attenuates morphine-induced rewarding in a neuropathic pain model","volume":"449","author":"Wu","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0320","doi-asserted-by":"crossref","first-page":"12217","DOI":"10.1523\/JNEUROSCI.1053-15.2015","article-title":"Inflammatory Pain Promotes Increased Opioid Self-Administration: Role of Dysregulated Ventral Tegmental Area \u03bc Opioid Receptors","volume":"35","author":"Hip\u00f3lito","year":"2015","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0325","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1016\/0024-3205(89)90062-3","article-title":"Morphine self-administration in the rat during adjuvant-induced arthritis","volume":"45","author":"Lyness","year":"1989","journal-title":"Life Sci."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0330","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1037\/a0013597","article-title":"Chronic pain alters drug self-administration: implications for addiction and pain mechanisms","volume":"16","author":"Martin","year":"2008","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079239","article-title":"Effect of chronic pain on fentanyl self-administration in mice","volume":"8","author":"Wade","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.cobeha.2018.10.002_bib0340","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.pain.2003.12.015","article-title":"Chronic pain patients are impaired on an emotional decision-making task","volume":"108","author":"Apkarian","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.cobeha.2018.10.002_bib0345","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.neuron.2010.03.002","article-title":"Predicting value of pain and analgesia: nucleus accumbens response to noxious stimuli changes in the presence of chronic pain","volume":"66","author":"Baliki","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.cobeha.2018.10.002_bib0350","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.ejpain.2007.12.007","article-title":"Signal valence in the nucleus accumbens to pain onset and offset","volume":"12","author":"Becerra","year":"2008","journal-title":"Eur. J. Pain Lond. Engl."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2016.05.033","article-title":"Reward deficiency and anti-reward in pain chronification","author":"Borsook","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2013.06.003","article-title":"Pain and suicidality: insights from reward and addiction neuroscience","volume":"109","author":"Elman","year":"2013","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0365","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nature14188","article-title":"From circuits to behaviour in the amygdala","volume":"517","author":"Janak","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.cobeha.2018.10.002_bib0370","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2049-9256-1-9","article-title":"The amygdala between sensation and affect: a role in pain","volume":"1","author":"Veinante","year":"2013","journal-title":"J. Mol. Psychiatry"},{"key":"10.1016\/j.cobeha.2018.10.002_bib0375","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/hbm.22199","article-title":"The Human Amygdala and Pain: Evidence from Neuroimaging","volume":"35","author":"Simons","year":"2014","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0380","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1523\/JNEUROSCI.3799-15.2016","article-title":"Feeding and Reward Are Differentially Induced by Activating GABAergic Lateral Hypothalamic Projections to VTA","volume":"36","author":"Barbano","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0385","first-page":"851","article-title":"Intra-accumbal Orexin-1 Receptors are Involved in Antinociception Induced by Stimulation of the Lateral Hypothalamus in the Formalin Test as an Animal Model of Persistent Inflammatory Pain","volume":"15","author":"Jahangirvand","year":"2016","journal-title":"Iran. J. Pharm. Res. IJPR"},{"key":"10.1016\/j.cobeha.2018.10.002_bib0390","first-page":"444","article-title":"What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse\/addiction and\/or aberrant drug-related behaviors? A structured evidence-based review","volume":"9","author":"Fishbain","year":"2008","journal-title":"Pain Med. Malden Mass"},{"key":"10.1016\/j.cobeha.2018.10.002_bib0395","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/01.j.pain.0000460357.01998.f1","article-title":"Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis","volume":"156","author":"Vowles","year":"2015","journal-title":"Pain"},{"key":"10.1016\/j.cobeha.2018.10.002_sbref0400","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1126\/science.aai8636","article-title":"A nontoxic pain killer designed by modeling of pathological receptor conformations","volume":"355","author":"Spahn","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.cobeha.2018.10.002_sbref0405","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar3483","article-title":"A bifunctional nociceptin and mu opioid receptor agonist is analgesic without opioid side effects in nonhuman primates","volume":"10","author":"Ding","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cobeha.2018.10.002_sbref0410","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature19112","article-title":"Structure-based discovery of opioid analgesics with reduced side effects","volume":"537","author":"Manglik","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.cobeha.2018.10.002_sbref0415","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aai8441","article-title":"Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria","volume":"9","author":"Brust","year":"2016","journal-title":"Sci. Signal"},{"key":"10.1016\/j.cobeha.2018.10.002_bib0420","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.cell.2017.10.035","article-title":"Bias Factor and Therapeutic Window Correlate to Predict Safer Opioid Analgesics","volume":"171","author":"Schmid","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.cobeha.2018.10.002_bib0425","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1001\/jamainternmed.2014.4005","article-title":"Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999\u20132010","volume":"174","author":"Bachhuber","year":"2014","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0430","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.drugalcdep.2017.01.006","article-title":"Medical marijuana policies and hospitalizations related to marijuana and opioid pain reliever","volume":"173","author":"Shi","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0435","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s12160-016-9844-2","article-title":"Mindfulness Meditation for Chronic Pain: Systematic Review and Meta-analysis","volume":"51","author":"Hilton","year":"2017","journal-title":"Ann. Behav. Med."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0440","article-title":"Massage Therapy for Fibromyalgia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"9","author":"Li","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cobeha.2018.10.002_bib0445","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1001\/archinternmed.2012.3654","article-title":"Acupuncture for chronic pain: individual patient data meta-analysis","volume":"172","author":"Vickers","year":"2012","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0450","article-title":"Acupuncture for musculoskeletal pain: A meta-analysis and meta-regression of sham-controlled randomized clinical trials","volume":"6","author":"Yuan","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cobeha.2018.10.002_bib0455","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/nyas.13153","article-title":"Mindfulness meditation\u2013based pain relief: a mechanistic account","volume":"1373","author":"Zeidan","year":"2016","journal-title":"Ann. N. Y. Acad. Sci."}],"container-title":["Current Opinion in Behavioral Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352154618300809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352154618300809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T15:20:24Z","timestamp":1762442424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352154618300809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":91,"alternative-id":["S2352154618300809"],"URL":"https:\/\/doi.org\/10.1016\/j.cobeha.2018.10.002","relation":{},"ISSN":["2352-1546"],"issn-type":[{"value":"2352-1546","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pain And Opioid Systems, Implications In The Opioid Epidemic","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Behavioral Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cobeha.2018.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}